Research notes
Stay informed with the most recent market and company research insights.

Research Notes
October performance to weigh on fees and flows
Regal Partners
November 13, 2026
RPL has advised that CY26 fund performance fee revenue will be at least $122.7m (Consensus was at $168.9m), with no further material performance fees expected in 2H26 beyond the amount already received (1H26 $118.7m, plus $4.0m for July to October). This is around $46m below consensus and around $74m below our prior $196.6m forecast, and follows a sharp drawdown across Regal's hedge fund strategies in October (Figure 2). Management also expects Other Income to have no material impact on CY26 Normalised NPAT, reflecting the weak share price of Regal Asian Investments (ASX:RG8). >Net flows remain resilient, with $2.2bn of net inflows in the ten months to October (a 12th consecutive positive quarter) and FUM of around $22bn. >We cut CY26 Normalised NPAT by around 35% to $99.8m (EPS 22.8cps), trim CY27 and CY28 by around 10% and 5%, and lower our price target to A$4.00 (from A$4.25). With the recurring fee base intact, we retain our BUY recommendation; the key near-term risk is that soft performance pressures flows and amplifies the uncertainty around Phil King's planned retirement.
Philips partnership has big potential
Imricor Medical Systems
November 13, 2026
The regulatory clearance for atrial flutter (AF) is progressing with approval expected 1Q27. >At this stage revenues are modest. We look forward to an acceleration of revenue quarter over quarter particularly once the AF approval is received. Also, the Philips partnership has the potential to unlock significant revenue growth as the installed base and Philips sales team are unlocked. >We have made no changes to forecasts or target price (A$2.90). Our SPECULATIVE BUY recommendation is maintained.
Blasting ahead, with interest
Orica
November 12, 2026
Despite a number of external challenges, ORI’s FY26 result slightly beat consensus estimates. Underlying EBIT rose 6.5% (+11% in constant currency) and NPAT increased 9.0%. Digital Solutions and Specialty Mining Chemicals (both +25% EBIT) drove the growth. Pleasingly, operating cashflow was also better than expected and the balance sheet is strong. >In FY27, ORI expects earnings growth from all three segments. Plant turnarounds and materially higher interest costs (+A$25-35m) mean modest NPAT growth. Growth should accelerate in FY28. We have made minor revisions to our forecasts. >We maintain an ACCUMULATE rating with a revised price target of A$26.98.
A strong start, a conservative 2H
Wagners
November 12, 2026
A positive AGM update. FY27 Operating EBIT guidance of $72m to $76m (+7% to +13%) brackets Consensus ($72.8m). 1H27 guidance of $40m to $42m was the standout, with the $41.0m midpoint 12% ahead of Consensus. The implied 2H27 (~$33m, 10% below Consensus) appears to reflect the full quantified cost and seasonality headwinds, with no credit for pricing, new capacity or the potential PNG LNG project (US$50m to US$55m, FID mid-December). We see risk skewed to the upside. >We lift FY27F/FY28F Operating EBIT by 3.5%/2% to $75.4m/$85.3m, in the upper half of guidance. Our target price rises to $5.90 (from $5.25) on a higher applied multiple. Buy rating retained.
Hitting restart on the rule of 40
Xero
November 12, 2026
XRO’s 1H27 result was broadly in line with expectations and comes with a small upgrade to FY27 guidance (including now expecting to hit Rule of 40 in FY27). >Shares have underperformed by ~50% over the past 12 months. The guidance upgrade, improving US/Melio traction, better articulation of XRO’s positioning in the context of AI and a newly announced A$1bn on-market buy-back are all positive news and, in our view, should be well received by investors. >We lift our Target Price to A$90 and retain our ACCUMULATE recommendation.
Momentum continues to build
Acrow
November 12, 2026
ACF provided a positive trading update with FY27 underlying EBITDA upgraded by ~5% at the mid-point. >The upgrade reflected a strong start to the financial year in both the Industrial Access and Construction segments. Pleasingly, management said the recent acquisitions of SuperDeck and AGIS are performing to expectations. >We increase FY27-29F underlying EBITDA by 6%. >Our target price rises to $1.45 (from $1.40) and we maintain our BUY rating. We remain positive on ACF following another upgrade to FY27 earnings guidance. Momentum continues to build across both the Industrial Access and Construction segments with a strong growth outlook over the medium term supported by increasing activity in QLD (including commercial, infrastructure and Brisbane Olympics), the Sydney Harbour Bridge refurbishment, and Snowy 2.0. Trading on 9.6x FY27F PE with a yield of 3.4%, we see the stock as undervalued relative to its growth outlook (3-year underlying EPS CAGR of 20%).
Model update
The Lottery Corporation
November 12, 2026
We have updated our forecasts on TLC after an improvement in jackpot outcomes since our September note. Our lottery tracker has swung from c.10% behind the pcp in mid-September to c.7% ahead on a cumulative draw basis. We lift FY27/28F Lotteries revenue by 2%/2% and Lotteries EBITDA by 5%/7%, with EPS up 5%/9%. Keno remains unchanged. >We retain our ACCUMULATE recommendation, with a revised 12-month target price of $5.90 (previously $5.40). The share price has rallied c.13% since our upgrade, so much of the rebound is already priced, albeit we note short interest remains elevated (c.9% SOI). At c.18x 12-month forward EV/EBITDA and a c.3.2% fully franked yield, the implied 12-month TSR of c.11% still looks good value in our view.
DFS delivered
Elementos
November 12, 2026
Elementos delivered a Definitive Feasibility Study (DFS) on its wholly-owned Oropesa tin project, Spain, with a pre-production cost of US$156M, producing 3,400tpy of tin in concentrate over 12 years, and now with the approval for 8.1km of road infrastructure, is progressing the key permitting, financing and offtake milestones toward a Final Investment Decision (FID). >With a binding agreement to acquire up to 50% ownership of the Robledollano smelter, 220km from Oropesa, ELT has the potential to create the only primary mine-to-metal tin supply within Europe, and establish one of the few vertically integrated primary tin supply chains globally. >Using a long-term tin price of US$37,000/t (currently US$47k/t) and a discount rate of 15% for Oropesa, our ELT Valuation is A$0.65ps, and our Target Price, with the Oropesa NPV discounted by 10% ahead of the FID, is A$0.60ps.
October FUM update
GQG Partners
November 12, 2026
GQG’s October update was very weak, with net outflows of US$6.7bn and negative investment performance of US$11bn taking FUM down 12% in the month to US$131.6bn. Year-to-date net outflows now total US$32.9bn, with no sign yet of stabilisation. >We downgrade FY26F/FY27F/FY28F EPS by 4%/27%/34% on lower FUM forecasts (weaker net flow and investment performance assumptions). To reflect higher risk, we cut our target PE from 8x to 5x and apply a 15% discount to our DCF. Our PT falls to A$0.82 (previously A$1.52). >The franchise retains inherent value if management can restore performance, but with momentum firmly to the downside, it is difficult to stay positive until we see signs of a turnaround. We move to HOLD.
Fully funded to first gold
Minerals 260
November 12, 2026
MI6 has received credit approved commitments from ANZ, NAB and Societe Generale for A$410m in debt facilities (A$335m Project Finance Facility and A$75m Working Capital Facility), which, alongside FNV royalty funding and the recent Placement, fully fund the Bullabulling development to first production. >Terms are in line with expectations but nonetheless attractive, with a margin of less than 3% above BBSY, a 7-year PFF tenor and no mandatory hedging. Financial close is expected in 1Q CY27, in line with DFS completion and FID. >We maintain our BUY rating and A$1.57ps price target.
News & insights
November 17, 2026
November 17, 2026
min read
Agricultural Investing Trends: Seasonal Supply Through an El Niño Cycle
Scott Fraser (AR: 001254347)
Financial Adviser
November 12, 2026
November 12, 2026
min read
Financial services internship: what one QUT student learned at Morgans
Morgans Opinion
Opinion
November 11, 2026
November 10, 2026
min read
Macro Monthly Market: A Worldly Lens - October 2026
Scott Fraser (AR: 001254347)
Financial Adviser


